Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors.

× No keyword cloud information.

11 in total

1. Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

Authors: Carmine Pinto; Carlo Antonio Barone; Giampiero Girolomoni; Elvio Grazioso Russi; Marco Carlo Merlano; Daris Ferrari; Evaristo Maiello
Journal: Oncologist Date: 2011-01-27

2. [Cutaneous side effects of EGF-receptor inhibition and their management].

Authors: R Gutzmer; T Werfel; A Kapp; J Elsner
Journal: Hautarzt Date: 2006-06 Impact factor: 0.751

3. [Cutaneous lesions due to inhibition of epidermal growth factor receptor].

Authors: E Bierhoff; H W Seifert; T Dirschka
Journal: Pathologe Date: 2006-02 Impact factor: 1.011

4. A case of cicatricial alopecia associated with erlotinib.

Authors: Bo Hee Yang; Chan Yl Bang; Ji Won Byun; Sung Hyub Han; Hee Jin Song; Seung Gyun In; Jeong Hyun Shin; Gwang Seong Choi
Journal: Ann Dermatol Date: 2011-12-27 Impact factor: 1.444

5. Gefitinib-induced hair alterations.

Authors: Song Zheng; Yue-Long Pan; Jiao-Li Wang; Ke-Er Huang; Ji-Hong Liu; Jian Wang; Xue-Qing Chen
Journal: BMJ Case Rep Date: 2009-03-17

6. Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors: M Fakih; M Vincent
Journal: Curr Oncol Date: 2010-07 Impact factor: 3.677

Review 7. Cetuximab: in the treatment of metastatic colorectal cancer.

Authors: Neil A Reynolds; Antona J Wagstaff
Journal: Drugs Date: 2004 Impact factor: 9.546

8. Severe acneiform eruption induced by cetuximab (Erbitux).

Authors: Jung Eun Lee; Sang Ju Lee; Hee Jung Lee; Ju Hee Lee; Kwang Hoon Lee
Journal: Yonsei Med J Date: 2008-10-31 Impact factor: 2.759

9. Neutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptor.

Authors: Nannie Bangsgaard; Mischa Houtkamp; Danita H Schuurhuis; Paul W H I Parren; Ole Baadsgaard; Hans W M Niessen; Lone Skov
Journal: PLoS One Date: 2012-06-25 Impact factor: 3.240

10. Dermatological Side Effects of Epidermal Growth Factor Receptor Inhibitors: 'PRIDE' Complex.

Authors: Bhushan Madke; Prachi Gole; Prabhash Kumar; Uday Khopkar
Journal: Indian J Dermatol Date: 2014-05 Impact factor: 1.494